Sanofi shared a post on LinkedIn:
“While important progress has been made in the treatment of multiple myeloma in recent years, we recognize there is still significant work to do to improve the lives of those living with this cancer.
Understanding and learning from multiple myeloma patients is a foundational part of our approach to advancing research for this difficult-to-treat cancer.
Read more from Elizabeth F. Franklin and Tom Snow on our commitment to patient-centric innovation in oncology.”
More posts featuring Sanofi on OncoDaily.